OTCMKTS:EVARF Lombard Medical (EVARF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Lombard Medical Stock (OTCMKTS:EVARF) Get Lombard Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Lombard Medical, Inc. (OTCMKTS: EVARF) is a medical device company focused on the development of minimally invasive endovascular systems for the treatment of aortic aneurysms. The company’s technology is designed to offer an alternative to traditional open surgery by sealing aneurysms within the vessel walls, reducing the risk of rupture and improving patient recovery times. The company’s flagship product is the Nellix EndoVascular Aneurysm Sealing (EVAS) System, which combines balloon-expandable stents encased in polymer-filled endobags to conform to patient anatomy and seal aneurysm sacs. Lombard Medical has pursued regulatory approvals and clinical studies to demonstrate the safety and efficacy of Nellix, including an investigational device exemption (IDE) study in the United States and CE mark clearance in Europe. Headquartered in Santa Clara, California, Lombard Medical serves interventional radiologists, vascular surgeons and hospitals across North America and Europe. The company’s leadership team brings together professionals with extensive experience in vascular medicine, regulatory affairs and medical device commercialization. Lombard Medical continues to advance its product pipeline and expand clinical adoption of its endovascular aneurysm sealing technology.AI Generated. May Contain Errors. Read More Receive EVARF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lombard Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVARF Stock News HeadlinesCapital Healthcare Properties and HSG Medical acquire Lombard medical office building for $3MMay 9, 2025 | bizjournals.comWhy travel insurance is essential for international tripsOctober 12, 2024 | msn.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.September 16 at 2:00 AM | American Alternative (Ad)Cherish Lombard: Mobile native, mom, wife, animal advocate and WKRG News 5 evening anchorOctober 11, 2024 | msn.comIndia's ICICI Lombard posts Q1 profit jump on motor, health insurance boostJuly 20, 2024 | reuters.comWeekend Break: WickedBall Chicago in Lombard has something for everyoneApril 16, 2024 | msn.comTrip cancelled due to Israel-Iran conflict? Here’s what your travel insurance company will sayApril 15, 2024 | msn.com18-year-old man charged with fatally shooting popular limo driver in AustinFebruary 8, 2024 | chicago.suntimes.comCSee More Headlines EVARF Stock Analysis - Frequently Asked Questions How were Lombard Medical's earnings last quarter? Lombard Medical, Inc. (OTCMKTS:EVARF) issued its earnings results on Thursday, October, 27th. The medical equipment provider reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.11. The medical equipment provider earned $3.04 million during the quarter, compared to analysts' expectations of $3.16 million. How do I buy shares of Lombard Medical? Shares of EVARF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings10/27/2016Today9/16/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolOTCMKTS:EVARF Previous SymbolNASDAQ:EVAR CIKN/A Webwww.lombardmedical.com Phone44121235750800Fax44-0-12-3575-0879Employees111Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (OTCMKTS:EVARF) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lombard Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lombard Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.